Islamabad: The Pakistan Stock Exchange (PSX) benchmark KSE-100 index experienced a turbulent trading session, closing at 157,555, a decrease of 483 points. Trading volume contracted to 1,666 million shares compared to 2,048 million shares the previous...
Read More »Pakistan Stock Market Braces For Further Decline
Islamabad: The Pakistan Stock Exchange (PSX) benchmark KSE-100 index experienced a turbulent trading session, closing at 157,555, a decrease of 483 points. Trading volume contracted to 1,666 million shares compared to 2,048 million shares the previous...
Read More »Oppo A6 Pro To Launch In Pakistan With Enhanced Durability And Battery
Islamabad: OPPO A6 Pro is launching in Pakistan on September 26, 2025, promising enhanced durability, a larger battery, and improved performance. The successor to the OPPO A5 Pro, known for its military-grade toughness and IP69 water resistance, the A...
Read More »OGDC Fourth Quarter Earnings Exceed Forecasts Despite Drop
Islamabad: Oil and Gas Development Company (OGDC) reported a 15% quarter-over-quarter decline in earnings to Rs9.37 per share in the fourth quarter of fiscal year 2025. This brings the full-year earnings to Rs39.5 per share, a 19% year-over-year decre...
Read More »KCCI Seeks Income, Sales Tax Deadline Extension
Islamabad: The Karachi Chamber of Commerce and Industry (KCCI) has formally requested the Federal Board of Revenue (FBR) to postpone the deadlines for filing income and sales tax returns. KCCI President Muhammad Jawed Bilwani appealed to FBR Chairman ...
Read More »Pakistan Tackles Power Sector Debt With $1.25 Trillion Financing Deal
Islamabad: Pakistan is set to sign a landmark financing agreement worth approximately $1.25 trillion to address its crippling power sector circular debt. The signing ceremony is scheduled for tomorrow, September 24, 2025, at the Prime Minister’s Offic...
Read More »GlaxoSmithKline Pakistan Poised For Significant Growth, Analysts Say
Islamabad: GlaxoSmithKline Pakistan Limited (GLAXO) is expected to see its share price rise by 36% to Rs610, according to analysts at JS Global who have initiated coverage on the pharmaceutical company with a "Buy" rating. The projection is based on i...
Read More »
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service